Data provision medicine shortages
Update March 2022
In order to enable a simple integration of current contents of the „Shortages catalogue“ into external IT systems, two endpoints are provided in a pilot operation. No authentication is required.
The underlying instructions for use are available at: https://www.basg.gv.at/fuer-unternehmen/online-service/nutzungshinweise
Endpoint public Internet | https://webservices.basg.gv.at/medicineshortage/export/v1/download |
Endpoint GIN | https://webservices-ginet.basg.gv.at/medicineshortage/export/v1/download |
General information
Since February 1, 2018, marketing authorisation holders and their authorised representatives have to submit medicine shortages electronically by using the application eService "Marketing Authorisation & Lifecycle Management of Medicines".
Medicine shortages are published on the „Shortages catalogue“ on the actual date of beginning of the shortage.
Marketing authorisation holders and their authorised representatives have to submit medicine shortages because of the regulation on ensuring the provision of medicinal products, that enters into force as from April 1, 2020, and because of the "Arzneimittelbetriebsordnung 2009". They are now obliged to report any restriction in supply of prescription-only human medicinal products using the eService.
The notification of a shortage affecting veterinary medicinal products and over-the-counter medicinal products is voluntary, if it is not subject to notification in accordance with the "Arzneimittelbetriebsordnung 2009".
Since December 10, 2020, the BASG has also been offering the contents of the "Shortages catalogue", including information on parallelexport bans, in machine-readable form (XML).
- VertriebseinschraenkungenASP.xml| 981 KB11/10/2024
In principle, the data export contains all shortages notifications that are also displayed in the „Shortages catalogue“. Not included are those notifications for which a resupply date has already been entered by the distributor for all affected packages and this resupply date has already been reached.
This means that pack sizes of a reported proprietary medicinal product that are reported as "not available", "restricted availability", "available acc. to § 4 (1)" or "available" will be made available in the XML as long as the report has not been completed by reavailability of all packs concerned. Please pay attention to the respective status of the packages when processing the data.
To simplify the processing of the reports, the provision is grouped according to PIP codes.
A provision of REST-based API retrieval options is already being planned and is expected to be completed from Q2/2022.
Release Notes
The data file is created daily (between 0:00 and 4:00 am) and made available on the BASG website under "Data provision medicine shortages".
XML schema: Contents and description of the export data
Designation of the data contents | Description |
File information | |
producedOn | Day and timestamp of the creation of the export file |
MD5sum | MD5 sum of the packs. Used to identify changes |
Pack size information | |
PZN | PIP code |
Packungsgroesse | Pack size |
Packungseinheit | Unit of pack size |
Packungscontainer | Container of pack size |
Packungsbeschreibung | Description of pack size |
Status | Status of the affected pack size. The following values are transmitted: not available, limited available, available according to §4 (1)*, available |
Beginn_Vertriebseinschraenkung | Beginning of the shortage of the pack size |
Datum_voraussichtliche_Wiederbelieferung | Expected supply of the pack size (if provided by the notifier) |
Notification information - | |
Melder | Name of the notifying company |
Datum_Meldung | Date of report |
Datum_letzte_Aenderung | Last modification date |
Mitteilung_Fachkreise | Information letter to healthcare professionals (yes/no) |
Rechtsgrundlage_Meldung | Legal basis of the notification |
Hinweis_BASG | Important BASG-information (optional) |
Information of the medicinal product per pack size | |
Zulassungsnummer | Marketing authorisation number |
Bezeichnung_Arzneispezialitaet | Name of the medicinal product |
Staerke | Strength |
Darreichungsform | Dosage form |
Parallelexportverbot | Parallelexport ban (yes/no) |
Zulassungsinhaber | Marketing authorisation holder |
Zulassungsinhaber_Tel | Telephone number of marketing authorisation holder |
Grund | Reason of the shortage |
Wirkstoffe | Active substances |